Jim Cramer Suggests Trimming Goldman Sachs (GS) and Wells Fargo (WFC) Positions for Different Reasons

On Thursday, stocks showed mixed performance as investors shifted focus from AI hardware to sectors like healthcare and financials. Jim Cramer noted that this rotation reflects a broader market trend rather than a decline in technology fundamentals. Healthcare stocks, including Eli Lilly and Johnson & Johnson, saw gains of approximately 5.5% and 2%, respectively.

Goldman Sachs reached an all-time high, rising over 4%, as it benefits from increased interest in financials and is positioned as a leader in upcoming IPOs. Cramer suggested that it may be prudent to trim positions in Goldman to lock in profits. Conversely, he expressed caution regarding Wells Fargo, which has not fully capitalized on sector opportunities.

CrowdStrike's shares fell about 7% despite a strong earnings report, as Cramer believes the market is underestimating the potential for growth in cybersecurity demand due to new AI-related threats. He anticipates that the impact of recent contracts will be more evident in future quarters, advising investors to consider this dip as a buying opportunity

Aktien in diesem Artikel

Unternehmen Preis Änderung Änderung % KI
CrowdStrike CRWD.US 691.53 +43.79 +6.76% Halten
Goldman Sachs Asset Management GS.US 1,035.64 +34.35 +3.43% Halten
Eli Lilly LLY.US 1,160.95 +24.58 +2.16% Kaufen
Wells Fargo WFC.US 82.40 +0.43 +0.52% Halten
Johnson & Johnson JNJ.US 238.33 -0.16 -0.07% Kaufen

Mehr economy Nachrichten